ID: ALA4562815

Max Phase: Preclinical

Molecular Formula: C25H28N2O6

Molecular Weight: 452.51

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOC(=O)Cn1nc2c(c1-c1cc(OC)c(OC)c(OC)c1)-c1ccc(OC)cc1CC2

Standard InChI:  InChI=1S/C25H28N2O6/c1-6-33-22(28)14-27-24(16-12-20(30-3)25(32-5)21(13-16)31-4)23-18-9-8-17(29-2)11-15(18)7-10-19(23)26-27/h8-9,11-13H,6-7,10,14H2,1-5H3

Standard InChI Key:  LFVCDCCUKKNKSU-UHFFFAOYSA-N

Associated Targets(Human)

COLO 205 50209 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Tubulin 2175 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 452.51Molecular Weight (Monoisotopic): 452.1947AlogP: 3.91#Rotatable Bonds: 8
Polar Surface Area: 81.04Molecular Species: NEUTRALHBA: 8HBD: 0
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.79CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.48Np Likeness Score: -0.32

References

1. Jiang J, Zhang Q, Guo J, Fang S, Zhou R, Zhu J, Chen X, Zhou Y, Zheng C..  (2019)  Synthesis and biological evaluation of 7-methoxy-1-(3,4,5-trimethoxyphenyl)-4,5-dihydro-2H-benzo[e]indazoles as new colchicine site inhibitors.,  29  (18): [PMID:31362922] [10.1016/j.bmcl.2019.07.042]

Source